{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:55:39Z","timestamp":1771653339187,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64868","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:07:05Z","timestamp":1721354825000},"source":"Crossref","is-referenced-by-count":1,"title":["Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated by Pachymeningitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Sanjay M","family":"Khaladkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajakta P","family":"KirdatPatil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryaman","family":"Dhande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeha A","family":"Jhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl M","year":"2013","unstructured":"Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013, 9:455-461. 10.1038\/nrneurol.2013.118","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-020-01088-6","article-title":"Immune-mediated disorders affecting the spinal cord and the spine","volume":"21","author":"Perez Giraldo GS","year":"2021","unstructured":"Perez Giraldo GS, Ortiz Garcia JG. Immune-mediated disorders affecting the spinal cord and the spine. Curr Neurol Neurosci Rep. 2021, 21:3. 10.1007\/s11910-020-01088-6","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl M","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019, 15:89-102. 10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25239","article-title":"Recurrent optic perineuritis with myelin oligodendrocyte glycoprotein antibody-associated disease complicated with granulomatous polyangiitis","volume":"14","author":"Nagahata K","year":"2022","unstructured":"Nagahata K, Suzuki S, Yokochi R, Nei Y, Hagino N. Recurrent optic perineuritis with myelin oligodendrocyte glycoprotein antibody-associated disease complicated with granulomatous polyangiitis. Cureus. 2022, 14:e25239. 10.7759\/cureus.25239","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102074","article-title":"MOG-antibody-associated hypertrophic pachymeningitis","volume":"42","author":"Papathanasiou A","year":"2020","unstructured":"Papathanasiou A, Yeo JM, Humberstone M, Hosseini AA. MOG-antibody-associated hypertrophic pachymeningitis. Mult Scler Relat Disord. 2020, 42:102074. 10.1016\/j.msard.2020.102074","journal-title":"Mult Scler Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody\u00a0disease","volume":"266","author":"Wynford-Thomas R","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V. Neurological update: MOG antibody\u00a0disease. J Neurol. 2019, 266:1280-1286. 10.1007\/s00415-018-9122-2","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007909","article-title":"Contrast enhancement of hypertrophic dura mater in MOG antibody-associated disease","volume":"93","author":"Ueno T","year":"2019","unstructured":"Ueno T, Kon T, Kaneko K, Takahashi T, Tomiyama M. Contrast enhancement of hypertrophic dura mater in MOG antibody-associated disease. Neurology. 2019, 93:271-272. 10.1212\/WNL.0000000000007909","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000007897","article-title":"Idiopathic hypertrophic pachymeningeal lesions: correlation between clinical patterns and neuroimaging characteristics","volume":"39","author":"Bang OY","year":"1998","unstructured":"Bang OY, Kim DI, Yoon SR, Choi IS. Idiopathic hypertrophic pachymeningeal lesions: correlation between clinical patterns and neuroimaging characteristics. Eur Neurol. 1998, 39:49-56. 10.1159\/000007897","journal-title":"Eur Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8863-1","article-title":"Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease","volume":"65","author":"De Virgilio A","year":"2017","unstructured":"De Virgilio A, de Vincentiis M, Inghilleri M, et al.. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res. 2017, 65:386-394. 10.1007\/s12026-016-8863-1","journal-title":"Immunol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000113748.53023.b7","article-title":"Idiopathic hypertrophic pachymeningitis","volume":"62","author":"Kupersmith MJ","year":"2004","unstructured":"Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ. Idiopathic hypertrophic pachymeningitis. Neurology. 2004, 62:686-694. 10.1212\/01.wnl.0000113748.53023.b7","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ibra.12099","article-title":"A case report: diagnosis and treatment of idiopathic hypertrophic pachymeningitis","author":"Luo Z","year":"2023","unstructured":"Luo Z, Cao P, Xu JQ, et al.. A case report: diagnosis and treatment of idiopathic hypertrophic pachymeningitis. iBrain. 2023, 1-5. 10.1002\/ibra.12099","journal-title":"iBrain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306410","article-title":"A nationwide survey of hypertrophic pachymeningitis in Japan","volume":"85","author":"Yonekawa T","year":"2014","unstructured":"Yonekawa T, Murai H, Utsuki S, et al.. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2014, 85:732-739. 10.1136\/jnnp-2013-306410","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269246-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-complicated-by-pachymeningitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T02:07:08Z","timestamp":1721354828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269246-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-complicated-by-pachymeningitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.64868","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}